Stockreport

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

AEON Biopharma, Inc. Class A  (AEON) 
PDF IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 [Read more]